JESSICA HINOJOSA: Open Payments
NPI 1730557844 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,041 in 52 payments from 12 companies in 2025. Trend: 2023 $625 · 2024 $736 · 2025 $1,041
Food & beverage: $1,041
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $381 |
| Ardelyx, Inc. | 12 | $267 |
| Phathom Pharmaceuticals, Inc. | 8 | $126 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $60 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| Aimmune Therapeutics, Inc. | 2 | $36 |
| Janssen Biotech, Inc. | 1 | $34 |
| KYOWA KIRIN, INC. | 1 | $21 |
| PFIZER INC. | 1 | $21 |
| Madrigal Pharmaceuticals | 1 | $17 |
Products named: IBSRELA, SKYRIZI, VOQUEZNA, CREON, LINZESS, XIFAXAN, ZENPEP, TREMFYA.
Industry payments across TX — which companies pay providers there.
